PHIBRO ANIMAL HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.73 USD | +2.33% |
|
-4.29% | +9.93% |
Chart calendar Phibro Animal Health Corporation
0ec801.ZQSu95rko1KvPjd_9iDfwsB1NZeeT9tS4cjtfEwAY6E.Dm3Hr-6OkAb_RFk0m2u9rookX8asEL8ehL6ETD5YAOoVY56j357TAcl1Yg~6d421139c8b351ee8a7f19e2ac669518
Upcoming events on Phibro Animal Health Corporation
Past events on Phibro Animal Health Corporation
| 18/03/2024 22:30 | Roth Conference |
| 12/03/2024 20:35 | Barclays Global Healthcare Conference |
| 29/02/2024 15:00 | BofA Securities Virtual Animal Health Summit |
| 08/02/2024 14:00 | Q2 2024 Earnings Call |
| 07/02/2024 21:30 | Q2 2024 Earnings Release |
| 09/11/2023 14:00 | Q1 2024 Earnings Call |
| 08/11/2023 21:34 | Q1 2024 Earnings Release |
| 06/11/2023 14:00 | Annual General Meeting |
| 31/08/2023 14:00 | Q4 2023 Earnings Call |
| 30/08/2023 21:40 | Q4 2023 Earnings Release |
| 10/05/2023 00:20 | Bank of America Healthcare Conference |
| 04/05/2023 14:00 | Q3 2023 Earnings Call |
| 03/05/2023 21:30 | Q3 2023 Earnings Release |
| 15/03/2023 14:45 | Barclays Global Healthcare Conference |
| 02/03/2023 15:50 | Bank of America Health Summit |
| 09/02/2023 14:00 | Interim 2023 Earnings Call |
| 08/02/2023 21:35 | Interim 2023 Earnings Release |
| 10/11/2022 14:00 | Q1 2023 Earnings Call |
| 09/11/2022 21:25 | Q1 2023 Earnings Release |
| 14/09/2022 14:10 | Morgan Stanley Global Healthcare Conference |
Past dividends on Phibro Animal Health Corporation
| 04/03/2024 | Quarterly 0.12 USD |
| 27/11/2023 | Quarterly 0.12 USD |
| 04/09/2023 | Quarterly 0.12 USD |
| 05/06/2023 | Quarterly 0.12 USD |
| 27/02/2023 | Quarterly 0.12 USD |
| 28/11/2022 | Quarterly 0.12 USD |
| 05/09/2022 | Quarterly 0.12 USD |
| 30/05/2022 | Quarterly 0.12 USD |
| 28/02/2022 | Quarterly 0.12 USD |
| 22/11/2021 | Quarterly 0.12 USD |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 828 830 -0.22% | 800 806 -0.65% | 833 827 0.73% | 942 938 0.41% | 978 979 -0.13% | 998 |
|
EBITDA Million USD | Released Forecast Spread | 118 123 -4.26% | 102 99,1 3.08% | 108 109 -0.87% | 111 111 -0.18% | 113 113 0.16% | 118 |
|
EBIT Million USD | Released Forecast Spread | 96,6 97,9 -1.28% | 78,7 75,2 4.69% | 84,7 85,3 -0.73% | 87,3 87,1 0.27% | 88,4 82,6 7.06% | 81,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 71,5 80,2 -10.8% | 55,5 49,3 12.57% | 66,5 63,8 4.23% | 0,00 0,00 - | 54,1 50,0 8.31% | 23,0 |
|
Net income Million USD | Released Forecast Spread | 54,7 58,8 -6.94% | 33,6 34,1 -1.6% | 54,4 46,1 18.04% | 49,2 54,6 -9.95% | 32,6 33,8 -3.42% | 15,2 |
|
EPS USD | Released Forecast Spread | 1,35 1,41 -4.09% | 0,83 0,84 -1.46% | 1,34 1,14 17.2% | 1,21 1,35 -10.37% | 0,81 0,84 -2.99% | 0,37 |
| Announcement Date | 27/08/19 | 26/08/20 | 25/08/21 | 24/08/22 | 30/08/23 | - |
Quarterly results
| Fiscal Period | Giugno | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 233 215 8.09% | 240 231 3.94% | 255 250 2.09% | 233 232 0.18% | 245 241 1.37% | 246 247 -0.4% | 255 256 -0.44% | 231 242 -4.44% | 250 241 3.72% | 254 | 265 |
|
EBITDA Million USD | Released Forecast Spread | 29,1 29,4 -0.91% | 28,0 29,4 -4.66% | 31,5 30,7 2.86% | 22,1 27,3 -18.93% | 30,9 26,0 18.74% | 27,4 30,1 -8.86% | 32,3 31,4 2.76% | 18,7 23,3 -19.85% | 29,5 26,4 11.54% | 37,7 | 40,4 |
|
EBIT Million USD | Released Forecast Spread | 23,3 22,8 2.32% | 21,8 22,7 -3.83% | 25,5 24,3 5.07% | 16,1 20,5 -21.47% | 24,8 18,3 35.72% | 21,3 22,3 -4.65% | 26,2 23,7 10.48% | 12,2 4,73 157.93% | 23,0 18,5 24.61% | 21,6 | 24,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 12,1 11,9 1.6% | 15,1 17,4 -13.42% | 21,4 17,3 23.49% | -12,0 -1,80 -566.67% | |||||||
|
Net income Million USD | Released Forecast Spread | 17,5 12,0 46.35% | 17,7 13,8 27.72% | 7,49 12,9 -42.07% | 3,90 10,8 -63.78% | 7,20 10,0 -28.1% | 10,0 11,9 -16.03% | 11,5 12,7 -9.11% | -8,00 -1,19 -572.27% | 1,30 6,20 -79.04% | 9,85 | 12,0 |
|
EPS USD | Released Forecast Spread | 0,43 0,30 43.33% | 0,44 0,34 29.41% | 0,18 0,32 -43.75% | 0,10 0,27 -62.96% | 0,18 0,25 -28% | 0,25 0,30 -15.25% | 0,28 0,32 -11.11% | -0,20 -0,03 -566.67% | 0,03 0,15 -80% | 0,24 | 0,30 |
| Announcement Date | 09/02/22 | 04/05/22 | 24/08/22 | 09/11/22 | 08/02/23 | 03/05/23 | 30/08/23 | 08/11/23 | 07/02/24 | - | - |
| 28/04/2024 | VETOQUINOL SA: Q1 2024 Sales and Revenue Release |
| 29/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 02/05/2024 06:45 | VIMIAN GROUP AB: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | ZOETIS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ELANCO ANIMAL HEALTH INCORPORATED: Q1 2024 Earnings Release |
| 07/05/2024 | PHIBRO ANIMAL HEALTH CORPORATION: Q3 2024 Earnings Release |
| 15/07/2024 | VIRBAC: Q2 2024 Sales and Revenue Release |
| 24/07/2024 | SWEDENCARE AB: Q2 2024 Earnings Release |
Past sector events for Phibro Animal Health Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PAHC Stock
- Calendar Phibro Animal Health Corporation
